Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Recruiting · NCT06787482 · Registry updated 2025-04-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Complications, Eye Diseases, Hereditary, age-related macular degeneration, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder, retinitis pigmentosa, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2025-04-25 | NCT06787482 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ace Cells Lab Limited | 3 |
| European Wellness Academy | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| British Center for Regeerative medicne (Cairo) | Giza | Egypt | 1 |
| Dr. Seif Clinic | Cairo | Egypt | 1 |